Category

Research
This article was originally published on The Limbic Australian blood cancer patients are being denied access to life-extending drugs and treatments because of long delays and excessive regulation by the Pharmaceutical Benefits Advisory Committee (PBAC), a parliamentary inquiry has been told. Leading haematologist Professor Andrew Spencer said the registry of myeloma cases established some eight...
Continue Reading
This article was originally published by Medical News Today Multiple myeloma is a type of blood cancer that affects plasma cells. Doctors use a three-step staging system to classify the severity of multiple myeloma and whether it has spread. A person may experience different types of symptoms in each stage, and survival rates will change...
Continue Reading
This article was originally posted by targeted Oncology Case: A 75-Year-Old Man with Multiple Myeloma Initial Presentation A 75-year-old man presents with worsening fatigue on exertion, pallor, and hip painPMH: osteoarthritisPE: tired appearing male, poor hand-grip strength, mild tenderness on palpation of the left hipECOG 2 Clinical workup Hb 9.8 g/dL, corrected calcium 11.9mg/dL, LDH 295U/L,...
Continue Reading
This article was originally published on TheLimbic Australian experts have been ‘startled’ to discover that many patients with multiple myeloma do not receive recommended imaging and staging, sparking concerns about missed diagnoses and overtreatment of benign forms of the disease. The findings come from an analysis of real-world data of more than 2400 newly diagnosed...
Continue Reading
This article was originally published on Cure While a diagnosis of multiple myeloma can be overwhelming for patients, the disease is very treatable, according to Dr. Andrew Yee. At CURE®’s Educated Patient® Summit on Multiple Myeloma, Yee, an assistant professor of medicine at Massachusetts General Hospital Cancer Center in Boston, discussed the signs and symptoms of...
Continue Reading
This article was originally published on Wiley Online Library There are currently limited Australian data on the outcomes of autologous stem cell transplantation (ASCT) in elderly multiple myeloma (MM) patients. We present the largest cohort of elderly MM patients aged ≥65 years undergoing ASCT in Australia and report their outcomes based on our two‐centre experience. Our...
Continue Reading
This article was originally posted on AJMC Multiple myeloma is not easily diagnosed, and its early symptoms may be confused for another condition. Each March, Multiple Myeloma Awareness Month puts multiple myeloma (MM) in the spotlight. A rare cancer, MM is not easily diagnosed early on, but it is the second most common blood cancer...
Continue Reading
This article was originally published by Urbanhealth Today ABSTRACT BACKGROUND: The current standard of care for multiple myeloma requires several regimens of treatment, with patients experiencing high symptom burden and side effects, which negatively impact health-related quality of life (HRQoL). Thus, it is crucial to understand patient perceptions of multiple myeloma and how patients value...
Continue Reading
This article was originally published on News Medical Life Sciences Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as...
Continue Reading
Dear Colleagues On behalf of Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) please find below our article of the week and the current IMS COVID-19 vaccination guidelines. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With CancerVan Poznak, Unger, Darke, Moinpour, Bagramian, Schubert, Hansen, Floyd, Dakhil, Lew, Wade, Fisch, Henry,...
Continue Reading
1 2 3 4 8

Floor 7, 90 The Terrace
Wellington Central
New Zealand